A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Immodulon Therapeutics Ltd
ClinicalTrials.gov Identifier:
NCT01559818
First received: March 19, 2012
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)